Autacoids1
Upcoming SlideShare
Loading in...5
×
 

Like this? Share it with your network

Share

Autacoids1

on

  • 1,854 views

 

Statistics

Views

Total Views
1,854
Views on SlideShare
1,854
Embed Views
0

Actions

Likes
2
Downloads
93
Comments
0

0 Embeds 0

No embeds

Accessibility

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Autacoids1 Presentation Transcript

  • 1. Autacoids By Dr Shah Murad [email_address]
  • 2.
    • Autacoids(autos>self :coid>remedy)(local hormones) are naturally occuring substances having widely different structures and pharmacological actions.
    • They include decarboxylated amino acids(histamine,serotonin),polypeptides(angiotensin,kinins,substance P,VIP) and ecosanoids(PGs,leukotrienes,thromboxanes)
  • 3. Common autacoids
    • Histamine
    • Serotonin
    • Ergot Alkaloids
    • Vasoactive peptides
  • 4.
    • Histamine: Storage and Release
    • Immunologic Release:
      • Most important mechanism
      • Mast cells, if sensitized by surface IgE antibodies, degranulate when exposed specific antigen
        •   Degranulation:
          • immediate (type I) allergic reaction
          • calcium-dependent, energy dependent
          • Release components:
            • histamine
            • ATP
            • other mediators present in granules
          •   Degranulation may also occurred subsequent to IgG-or IgM-mediated immune reactions
        • Release regulation:
          • present in most mast cells (not lung)
  • 5.
    • Histamine Modulation: immunologic/inflammatory responses
      • Histamine -- following local injury:
        • local vasodilation
        • acute inflammation mediator release--
          • inflammatory cells
            • neutrophils
            • eosinophils
            • basophils
            • monocytes
            • lymphocytes
      • Histamine --
        • inhibits some T and B lymphocyte function
        • inhibits release of lysosomal contents
        • Mechanism of Action:
          • H2 receptor activation
          • increasing intracellular cAMP
  • 6.
    •   Mechanical/Chemical Release:
    • Histamine displacement:
      • Morphine, tubocurarine: displacement of histamine from heparin-protein complex
      • Degranulation:
        • chemical or mechanical injury to mast cells
        • Physical trauma
  • 7.  
  • 8. Histamine
    • It is widely distributed in the body including
    • Mast cells
    • GIT
    • lungs
    • skin and
    • CNS
  • 9. Synthesis,storage and release of HISTAMINE
    • Beta 2,4 imidazole ethylamine(Histamine)is synthesized in the tissues by decarboxylation of histidine.
    • In the mast cells histamine is stored,bound to heparin.
    • It is released from mast cells by mechanical trauma,allergic reactions,ultraviolet radiation and by various chemicals and drugs(morphine,tubocurarine,stilbamidine,dextran)
  • 10.  
  • 11.
    • Overview of Mast Cells and Basophils Mast cells and basophils are the effector cells involved in the immediate hypersensitivity response . Found in tissues throughout the body, they are particularly associated with blood vessels and nerves and are in proximity to surfaces that border the external environment .
    • Both contain numerous osmophilic granules that contain heparin and other proteins that support mediators, including histamine, which alters cellular and vascular reactions.
    • Secretion of mediators occurs by degranulation during which the contents of the granules are exocytosed. Degranulation is provoked by certain chemical agents, C3a and C5a (two complement components) binding to surface receptors, certain drugs, and the IgE system .
    • Mast cells and basophils have receptors for IgE antibodies and can be activated to secrete mediators if IgE first binds to these receptors, followed by antigen binding to the Fab fragment of the fixed IgE molecules.
    • Degranulation can lead to allergic reactions or anaphylactic shock, in extreme cases
  • 12. Pharmacological actions
    • It acts through 2 types of receptors; H 1 and H 2 receptors.
    • Gastric,cardiac,probably central and some vascular actions of histamine are mediated through H 2 receptors.
    • All other effects are mediated by H 1 receptors.
    • There are species differences in the distribution of receptors.
  • 13. On CVS
    • Histamine causes relaxation of arterioles,constriction of veins,marked dilatation of capillaries,increased capillary permeability and relaxation of precapillary sphincters.
    • In man there is usuall fall in BP.
    • Cerebral vessels respond to histamine with dilatation,causing headache.
  • 14. On smooth muscles
    • It stimulates smooth muscle.
    • Bronchial smooth muscles are especially sensitive to large doses of histamine.
    • Intestinal and ureteral smooth muscles are contracted.
  • 15. Exocrine glands
    • Histamine by acting on H 2 receptors causes the secretion of large quantities of gastric juice rich in acid and pepsin.
    • Gastrin may act through the release of histamine,as the actions of both are blocked by H 2 receptor antagonists.
  • 16. On skin
    • triple response (of Lewis)   a triphasic skin reaction to being stroked with a blunt instrument: first a red line develops at the site due to histamine release, then a flare develops around the red line, and lastly a wheal is formed as a result of local edema.
  • 17.  
  • 18. On CNS
    • Large amount of histamine is found in various CNS structures
    • It may function as neuro-modulator
  • 19. Endocrine glands
    • Large doses of histamine provoke secretion of catecholamine from the adrenal medulla.
    • In acute inflammatory response ,histamine may initiate early changes such as the axon reflex and allergic response.
  • 20. Histamine and acute anaphylactic shock
    • During hypersensitivity reactions of the immediate type there is released of histamine from sensitized mast cells or basophils in response to specific antigen.
    • Histamine along with other constituents of the secretary granules is mainly responsible for acute anaphylactic shock
  • 21.
    • Histamine, acting on H1-receptors, produces pruritus , vasodilatation , hypotension , flushing , headache , tachycardia , bronchoconstriction , increase in vascular permeability , potentiation of pain , and more.
    • While H1-antihistamines help against these effects, they work only if taken before contact with the allergen. In severe allergies, such as anaphylaxis or angioedema , these effects may be so severe as to be life-threatening. Additional administration of epinephrine , often in the form of an autoinjector ( Epi -pen ), is required by people with such hypersensitivities.
  • 22. Therapeutic uses
    • Histamine was used in past for tests of gastric secretary function and for diagnosis of pheochromocytoma.
    • BETAZOLE (Histalog) is a synthetic analogue of histamine which stimulate the secretion of gastric acid with fewer side effects as compared to histamine. IT IS USED FOR TEST FOR GASTRIC SECRETION in the dose of 50mg subcutaneously.
  • 23.
    • H1 antagonist
    • An H1 antagonist is a histamine antagonist of the H1 receptor that serves to reduce or eliminate effects mediated by histamine , an endogenous chemical mediator released during allergic reactions . Agents where the main therapeutic effect is mediated by negative modulation of histamine receptors are termed antihistamines - other agents may have antihistaminergic action but are not true antihistamines.
    • In common use, the term "antihistamine" refers only to H1 antagonists, also known as H1-receptor antagonists and H1-antihistamines. It has been discovered that these H1-antihistamines are actually inverse agonists at the histamine H1-receptor, rather than antagonists
  • 24.
    • Clinical use of H1-antihistamines
    • H1-antihistamines are clinically used in the treatment of histamine-mediated allergic conditions. Specifically, these indications may include:
    • Allergic rhinitis
    • Allergic conjunctivitis
    • Allergic dermatological conditions ( contact dermatitis )
    • Urticaria
    • Angioedema
    • Diarrhea
    • Pruritus ( atopic dermatitis , insect bites)
    • Anaphylactic or anaphylactoid reactions - adjunct only
    • Nausea and vomiting (first-generation H1-antihistamines)
    • Sedation (first-generation H1-antihistamines)
  • 25.
    • H1-antihistamines can be administered topically (through the skin , nose , or eyes ) or systemically, based on the nature of the allergic condition.
  • 26. First-generation (non-selective, classical)
    • These are the oldest H1-antihistaminergic drugs and are relatively inexpensive and widely available. They are effective in the relief of allergic symptoms, but are typically moderately to highly-potent muscarinic acetylcholine receptor -antagonists ( anticholinergic ) agents as well. These agents also commonly have action at α- adrenergic receptors and/or 5-HT receptors .
    • This lack of receptor-selectivity is the basis of the poor tolerability-profile of some of these agents, especially compared with the second-generation H1-antihistamines.
    • Patient response and occurrence of adverse drug reactions vary greatly between classes and between agents within classes.
  • 27. Ethylene-diamines
    • Ethylenediamines were the first group of clinically-effective H1-antihistamines developed.
    • Mepyramine (pyrilamine)
    • Antazoline
  • 28. Ethanolamines
    • Diphenhydramine was the prototypical agent in this group. Significant anticholinergic adverse effects, as well as sedation, are observed in this group but the incidence of gastrointestinal adverse effects is relatively low.
    • Diphenhydramine
    • Carbinoxamine
    • Doxylamine
    • Clemastine
    • Dimenhydrinate
  • 29. Alkylamines
    • The isomerism is a significant factor in the activity of the agents in this group. E -triprolidine, for example, is 1000-fold more potent than Z -triprolidine. This difference relates to the positioning and fit of the molecules in the histamine H1-receptor binding site. Alkylamines are considered to have relatively fewer sedative and gastrointestinal adverse effects, but relatively greater incidence of paradoxical CNS stimulation
    • EG: Pheniramine
    • Chlorphenamine (chlorpheniramine)
    • Dexchlorpheniramine
    • Brompheniramine
    • Triprolidine
  • 30. Piperazines
    • These compounds are structurally-related to the ethylenediamines and the ethanolamines, and produce significant anticholinergic adverse effects. Compounds from this group are often used for motion sickness, vertigo, nausea, and vomiting. The second-generation H1-antihistamine cetirizine also belongs to this chemical group…EG: Cyclizine
    • Chlorcyclizine
    • Hydroxyzine
    • Meclizine
  • 31. Tricyclics and Tetracyclics
    • These compounds differ from the phenothiazine antipsychotics in the ring-substitution and chain characteristics.
    • A ntidepressants (and tetracyclics ), explain the H1-antihistaminergic adverse effects of those drug classes and also the poor tolerability profile of tricyclic H1-antihistamines. The second-generation H1-antihistamine loratadine was derived from compounds in this group.EG: Promethazine
    • Alimemazine (trimeprazine)
    • Cyproheptadine
    • Azatadine
    • Ketotifen
  • 32. Second-generation and third-generation (selective, non-sedating)
    • Second generation H1-antihistamines are newer drugs that are much more selective for peripheral H1 receptors in preference to the central nervous system histaminergic and cholinergic receptors. This selectivity significantly reduces the occurrence of adverse drug reactions compared with first-generation agents, while still providing effective relief of allergic conditions.
    • Third-generation H1-antihistamines are the active enantiomer (levocetirizine) or metabolite (desloratadine & fexofenadine) derivatives of second-generation drugs intended to have increased efficacy with fewer adverse drug reactions .
    • Indeed, fexofenadine is associated with a decreased risk of cardiac arrhythmia compared to terfenadine. However, there is little evidence for any advantage of levocetirizine or desloratadine, compared to cetirizine or loratadine , respectively.
  • 33. Systemic, second-generation
    • Acrivastine
    • Astemizole
    • Cetirizine
    • Loratadine
    • Mizolastine
    • Terfenadine
  • 34.
    • In the 1980's a new group of antihistamines was developed, which has got, besides its increased efficiency, fewer by effects.
    • Considering their pharmacokinetic characteristics and effects, the requirements the modern second generation antihistamine should meet, can be summarized as follows:
    • The modern antihistamine should be selective,
    • Peripheral H1 receptor antagonist,
    • Should have a low affinity to the H1 receptors of the brain,
    • Be void of anticholinerg and antiserotonin effect,
    • Should stabilize the membrane of the mastocytes.
    • The introduction of modern, second generation antihistamines was started by terfenadin in 1985, and was followed by astemizole, loratadine and cetirizine in 1988.
  • 35.
    • Topical, second-generation
    • Azelastine
    • Levocabastine
    • Olopatadine
  • 36.
    • First-generation antihistamines, which were introduced before the 1980’s, are modestly effective, but would probably not have been approved for use if introduced today because of their sedative and psychomotor side effects. The second-generation antihistamines terfenadine and astemizole were the first non-sedating antihistamines, but are no longer in common use in most countries due to potential cardiac effects.
    • The second-generation drugs have less propensity to cross the blood-brain barrier than first-generation antihistamines, are thus much less likely to cause sedation, and do not cause dry mouth and urinary dysfunction
  • 37.
    • There are currently several next-generation antihistamines approved or in development . These drugs are either active metabolites or an enantiomer (mirror image) of a second-generation antihistamine.
    • Levocetirizine is currently in use in Europe and the United Kingdom. Fexofenadine is in use worldwide.
  • 38. Systemic, third-generation
    • Levocetirizine
    • Desloratadine
    • Fexofenadine
  • 39. Selected Next-Generation Antihistamines and Their Relationship to Second-Generation Drugs
    • Next-generation antihistamine - Fexofenadine - Desloratadine - Levocetirizine - Tecastemizole
    • Chemical relationship to second-generation antihistamine -Metabolite of terfenadine -Metabolite of loratadine -Enantiomer of cetirizine -Metabolite of astemizole
  • 40.
    • Antihistamines, among the most commonly prescribed drugs in the world, have evolved considerably since the first generation was introduced > 50 years ago.
    • The first generation antihistamines (e.g., chlorpheniramine, diphenhydramine, promethazine and hydroxyzine) are still widely available and in use today.
    • These drugs have considerable sedative effects caused by their ability to cross the blood–brain barrier.
    • The next generation of antihistamines to emerge in the market were devoid of these sedative effects; however, two (terfenadine and astemizole) have shown rare but lethal cardiotoxic side effects.
    • .
  • 41.
    • The third generation antihistamines, metabolites of the earlier drugs, have demonstrated no cardiac effects of the parent drugs and are at least as potent.
    • Many have exhibited superior pharmacokinetic and pharmacological profiles, including an improved onset of action and duration of effect.
    • The clinical benefit of these newer oral antihistamines will clearly help improve the quality of life of patients with chronic allergies
  • 42. Serotonin (5-Hydroxytrptamine)
    • 5-Hydroxytryptamine or 3-(2-aminoethyl)-1 H -indol-5-ol
    • MOLECULAR FORMULA: C 10 H 12 N 2 O
    • MOLECULAR MASS: 176.215
  • 43.  
  • 44.
    • Isolated and named in 1948 , It was initially identified as a vasoconstrictor substance in blood serum – hence serotonin , a serum agent affecting vascular tone. This agent was later chemically identified as 5-hydroxytryptamine (5-HT) by Rapport, and, as the broad range of physiological roles were elucidated, 5-HT became the preferred name in the pharmacological field.
  • 45.
    • Serotonin ( 5-hydroxytryptamine , or 5-HT ) is a monoamine neurotransmitter synthesized in serotonergic neurons in the central nervous system (CNS) and enterochromaffin cells in the gastrointestinal tract of animals including humans . Serotonin is also found in many mushrooms and plants , including fruits and vegetables
  • 46.
    • In the central nervous system , serotonin is believed to play an important role as a neurotransmitter , in the modulation of anger , aggression , body temperature , mood , sleep , sexuality , and appetite as well as stimulating vomiting .
    • In addition, serotonin is also a peripheral signal mediator. For instance, serotonin is found extensively in the human gastrointestinal tract (about 80-90% of the body's total serotonin is found in the enterochromaffin cells in the gut).
    • In the blood, the major storage site is platelets , which collect serotonin for use in mediating post-injury vasoconstriction.
  • 47.
    • Neurotransmission
    • As with all neurotransmitters, the effects of 5-HT on the human mood and state of mind and its role in consciousness are very difficult to ascertain
  • 48.
    • 5-HT is thought to be released from serotonergic varicosities into the extra neuronal space, in other words from swellings (varicosities) along the axon, rather than from synaptic terminal boutons (in the manner of classical neurotransmission).
    • From here it is free to diffuse over a relatively large region of space (>20µm) and activate 5-HT receptors located on the dendrites , cell bodies and presynaptic terminals of adjacent neurons.
  • 49.
    • 5-HT receptors are the receptors for serotonin. They are located on the cell membrane of nerve cells and other cell types in animals and mediate the effects of serotonin as the endogenous ligand and of a broad range of pharmaceutical and hallucinogenic drugs .
    • With the exception of the 5-HT3 receptor , a ligand gated ion channel , all other 5-HT receptors are G protein coupled seven transmembrane (or heptahelical ) receptors that activate an intracellular second messenger cascade.
  • 50.
    • Genetic variations in alleles which code for serotonin receptors are now known to have a significant impact on the likelihood of the appearance of certain psychological disorders and problems.
    • For instance, a mutation in the allele which codes for the 5-HT2A receptor appears to double the risk of suicide for those with that genotype
  • 51.
    • Serotonergic action is terminated primarily via uptake of 5-HT from the synapse. This is through the specific monoamine transporter for 5-HT, 5-HT reuptake transporter , on the presynaptic neuron.
    • Various agents can inhibit 5-HT reuptake including MDMA (ecstasy), amphetamine , cocaine , dextromethorphan (an antitussive ), tricyclic antidepressants (TCAs) and selective serotonin reuptake inhibitors (SSRIs).
  • 52.
    • Other functions
    • Recent research suggests that serotonin plays an important role in liver regeneration and acts as a mitogen (induces cell division) throughout the body
  • 53.
    • Pathology
    • If neurons that make serotonin — serotonergic neurons — are abnormal in infants, there is a risk of sudden infant death syndrome (SIDS).
    • Low levels of serotonin may also be associated with intense religious experiences . [10]
    • Recent research shows that in both patients who suffer from depression and in mice that model the disorder, levels of the p11 protein are decreased. This protein is related to serotonin transmission within the brain
  • 54. The pathway for the synthesis of serotonin from tryptophan
    • In the body, serotonin is synthesized from the amino acid tryptophan by a short metabolic pathway consisting of two enzymes : tryptophan hydroxylase (TPH) and amino acid decarboxylase (DDC). The TPH-mediated reaction is the rate-limiting step in the pathway. TPH has been shown to exist in two forms: TPH1, found in several tissues , and TPH2, which is a brain-specific isoform .
    • There is evidence that genetic polymorphisms in both these subtypes influence susceptibility to anxiety and depression.
    • There is also evidence that ovarian hormones can affect the expression of TPH in various species, suggesting a possible mechanism for postpartum depression and premenstrual stress syndrome .
  • 55.
    • Serotonin taken orally does not pass into the serotonergic pathways of the central nervous system because it does not cross the blood-brain barrier .
    • However, tryptophan and its metabolite 5-hydroxytryptophan (5-HTP), from which serotonin is synthesized, can and do cross the blood-brain barrier. These agents are available as dietary supplements and may be effective serotonergic agents
  • 56.
    • One product of serotonin breakdown is 5-Hydroxyindoleacetic acid (5 HIAA), which is excreted in the urine . Serotonin and 5 HIAA are sometimes produced in excess amounts by certain tumors or cancers , and levels of these substances may be measured in the urine to test for these tumors
  • 57. Serotonergic drugs
    • Several classes of drugs target the 5-HT system including some antidepressants , antipsychotics , anxiolytics , antiemetics , and antimigraine drugs as well as the psychedelic drugs and empathogens
  • 58. Psychoactive drugs
    • The psychedelic drugs psilocin / psilocybin , DMT , mescaline , and LSD mimick the action of serotonin at 5-HT2A receptors . The empathogen MDMA (ecstasy) releases serotonin from synaptic vesicles of neurons
  • 59. Antidepressants
    • The MAOIs prevent the breakdown of monoamine neurotransmitters (including serotonin), and therefore increase concentrations of the neurotransmitter in the brain. MAOI therapy is associated with many adverse drug reactions, and patients are at risk of hypertensive emergency triggered by foods with high tyramine content and certain drugs
  • 60.
    • Some drugs inhibit this re-uptake of serotonin, again making it stay in the synapse longer. The tricyclic antidepressants (TCAs) inhibit the re-uptake of both serotonin and norepinephrine . The newer selective serotonin re-uptake inhibitors ( SSRIs ) have fewer (though still numerous) side-effects and fewer interactions with other drugs
  • 61. Antiemetics
    • 5-HT3 antagonists such as ondansetron , granisetron , and tropisetron are important antiemetic agents. They are particularly important in treating the nausea and vomiting that occur during anticancer chemotherapy using cytotoxic drugs.
    • Another application is in treatment of post-operative nausea and vomiting. Applications to the treatment of depression and other mental and psychological conditions have also been investigated with some positive results
  • 62. Serotonin syndrome
    • Extremely high levels of serotonin can have toxic and potentially fatal effects, causing a condition known as serotonin syndrome .
    • such toxic levels are essentially impossible to reach through an overdose of a single anti-depressant drug, but require a combination of serotonergic agents, such as an SSRI with an MAOI .
  • 63. Chronic diseases resulting from serotonin 5-HT2B overstimulation
    • Cardiac fibrosis
    • In blood, serotonin stored in platelets is active wherever platelets bind, as a vasoconstrictor to stop bleeding, and also as a fibrocyte mitotic, to aid healing.
    • Because of these effects, overdoses of serotonin, or serotonin agonist drugs, may cause acute or chronic pulmonary hypertension from pulmonary vasoconstriction, or else syndromes of retroperitoneal fibrosis or cardiac valve fibrosis ( endocardial fibrosis )
  • 64.
    • Serotonin itself may cause a syndrome of cardiac fibrosis when it is eaten in large quantities in the diet (the Matoki banana of East Africa) or when it is over-secreted by certain mid-gut carcinoid tumors.
  • 65.
    • Serotonergic agonist drugs in overdose in experimental animals not only cause acute (and sometimes fatal) pulmonary hypertension , but chronic use of certain of these drugs produce a chronic pulmonary hypertensive syndrome in humans, also.
    • Some serotinergic agonist drugs also cause fibrosis anywhere in the body, particularly the syndrome of retroperitoneal fibrosis , as well as cardiac valve fibrosis
  • 66.
    • three groups of serotonergic drugs have been linked with these syndromes. They are the serotonergic vasoconstrictive anti-migraine drugs ( ergotamine and methysergide ), the serotonergic appetite suppressant drugs ( fenfluramine , chlorphentermine , and aminorex ), and certain anti-parkinsonian dopaminergic agonists, which also stimulate serotonergic 5-HT2B receptors. These include pergolide and cabergoline
    • As with fenfluramine, some of these drugs have been withdrawn from the market after groups taking them showed a statistical increase of one or more of the side effects described. An example is pergolide .
  • 67.
    • Amino acid L-tryptophan and SSRI -class antidepressants don’t raise blood serotonin levels>>>>>>>>, they are not under suspicion to cause the syndromes described.
    • However, since 5-hydroxytryptophan ( 5-HTP ) does raise blood serotonin levels, it is under some of the same scrutiny as actively serotonergic drugs
  • 68. Illness Caused by lack of serotonin
    • Obsessive-compulsive disorder (OCD) can be a debilitating disorder with the following two anxiety-related essential features: obsessions (undesirable, recurrent, disturbing thoughts) and compulsions (repetitive or ritualized behaviors).
    • it may have to do with serotonin, which helps to keep people from repeating the same behaviors over and over again.
  • 69.
    • A person who has OCD may not have enough serotonin. Therefore, many people who have OCD can function better when they take medicines that increase the amount of serotonin in their brain
  • 70. She has headache
  • 71. He also have
  • 72. She is crying for her headache
  • 73.  
  • 74.  
  • 75.  
  • 76.  
  • 77.  
  • 78.  
  • 79.  
  • 80.  
  • 81.  
  • 82.  
  • 83.  
  • 84.  
  • 85. GIVE THEM PROPER TREATMENT
  • 86.
    • ERGOT ALKALODS
  • 87.  
  • 88.  
  • 89.  
  • 90.  
  • 91.  
  • 92.  
  • 93.  
  • 94.  
  • 95.  
  • 96.  
  • 97.  
  • 98.  
  • 99.  
  • 100.  
  • 101.  
  • 102.  
  • 103.  
  • 104.  
  • 105.  
  • 106.  
  • 107.